| |
Trustee Archive
Lung cancer is a disease characterized by uncontrolled cell growth in the tissues of the lung. If left untreated, this growth can spread to other parts of the body. Smoking tobacco is the most common cause of this disease, responsible for more than 80% of all lung cancer cases. Lung cancer accounts for 14% of all new cancers and is the most common cancer in men and women, behind prostate and breast cancers. Lung cancer is, by far, the leading cause of cancer death in America, outpacing breast, colon and prostate cancers combined. Nearly 225,000 new lung cancer cases are diagnosed each year and nearly 136,000 deaths annually result from this disease. About two-thirds of those diagnosed with lung cancer are 65 or older, with the average age at the time of diagnosis being about 70. Exposure to radon accounts for approximately 21,000 deaths from lung cancer each year and is the second leading cause of lung cancer in non-smokers. Currently, there are more than 541,000 American survivors of lung cancer.
Recent studies have shown a higher incidence of lung cancer for non-smoking women compared to non-smoking men, and found the relative risk of developing lung cancer has increased tenfold among female smokers between 1959 and 2010. Advocates say more research to be done to explain the gender differences of this disease.
Pending Legislation: S.2245 - Women and Lung Cancer Research and Preventive Services Act of 2023
Sponsor: Sen. Marco Rubio (FL)
Status: Senate Committee on Health, Education, Labor, and Pensions
Chair: Sen. Bernie Sanders (VT) |
- I oppose reforming current lung cancer policy and wish to donate resources to the campaign committee of Leader Charles Schumer (NY).
- I support commissioning a review to understand the current state of research on lung cancer in women, accessibility of services to prevent lung cancer, and public education materials on the topic of lung cancer by:
1.) Developing a report on the current landscape, knowledge gaps, and opportunities to improve upon our knowledge of lung cancer in women.
2.) Requiring this report to highlight both environmental and genetic contributions to lung cancer in women.
And wish to donate resources to the campaign committee of Sen. Bernie Sanders (VT) and/or to an advocate group currently working with this issue.
|
|
| Winning Option
»» No issues were voted |
-
I support commissioning a review to understand the current state of research on lung cancer in women, accessibility of services to prevent lung cancer, and public education materials on the topic of lung cancer by:
1.) Developing a report on the current landscape, knowledge gaps, and opportunities to improve upon our knowledge of lung cancer in women.
2.) Requiring this report to highlight both environmental and genetic contributions to lung cancer in women.
And wish to donate resources to the campaign committee of Sen. Bernie Sanders (VT) and/or to an advocate group currently working with this issue.
|
- Senator
If elected as a trustee, the campaign committee of Sen. Bernie Sanders (VT) will be unconditionally awarded the funds pledged to this issue along with a letter requesting him to favorably consider passing S.2245 - Women and Lung Cancer Research and Preventive Services Act of 2023 .
- LUNGevity Foundation
If elected as a trustee, LUNGevity Foundation will be awarded the funds pledged to this issue along with a letter requesting these funds be used to expand its efforts to prevent, treat and cure lung cancer.
About: LUNGevity is changing outcomes for people with lung cancer through research, education, and support. We are dedicated to funding scientific research because the link between research spending and improved survival is clear. Our strategic investment in both early detection and therapeutics will help people live better with lung cancer and dramatically improve on the current 19% five-year survival rate. While we fund primary research, we also conduct patient-focused research to better understand their unmet needs and convene multi-stakeholder meetings to streamline the research process and accelerate progress to patients.
|
- No trustee votes received.
|
| Poll Opening Date |
September 11, 2023 |
| Poll Closing Date |
September 17, 2023 |
|
|
